Treatment

PACLITAXEL, INFLIXIMAB, volrustomig, CISPLATIN, MYCOPHENOLATE MOFETIL, FLUOROURACIL clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedTherapeutic exploratory (Phase II)
A Phase II, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Volrustomig as Monotherapy or in Combination with Anti-cancer Agents in Participants with Advanced/Metastatic Solid Tumors (eVOLVE-02)
This study is looking into a new treatment called volrustomig for people with certain advanced or spreading cancers. Researchers want to see how well it works and if it's safe, either on its own or with other cancer drugs.
For: Sub-study 5: Unresectable Pleural Mesothelioma (Volrustomig Monotherapy), Sub-study 4: Esophageal Squamous Cell Carcinoma (Volrustomig in Combination with Chemotherapy).
Italy · Germany